chr4-109728735-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_030821.5(PLA2G12A):c.208+867C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.622 in 152,096 control chromosomes in the GnomAD database, including 30,716 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.62 ( 30716 hom., cov: 32)
Consequence
PLA2G12A
NM_030821.5 intron
NM_030821.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0170
Publications
20 publications found
Genes affected
PLA2G12A (HGNC:18554): (phospholipase A2 group XIIA) Secreted phospholipase A2 (sPLA2) enzymes liberate arachidonic acid from phospholipids for production of eicosanoids and exert a variety of physiologic and pathologic effects. Group XII sPLA2s, such as PLA2G12A, have relatively low specific activity and are structurally and functionally distinct from other sPLA2s (Gelb et al., 2000 [PubMed 11031251]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.81 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PLA2G12A | ENST00000243501.10 | c.208+867C>A | intron_variant | Intron 1 of 3 | 1 | NM_030821.5 | ENSP00000243501.5 | |||
| ENSG00000285330 | ENST00000645635.1 | c.1535-9976C>A | intron_variant | Intron 12 of 14 | ENSP00000493607.1 | |||||
| PLA2G12A | ENST00000502283.1 | c.208+867C>A | intron_variant | Intron 1 of 3 | 1 | ENSP00000425274.1 | ||||
| PLA2G12A | ENST00000507961.1 | n.208+867C>A | intron_variant | Intron 1 of 2 | 2 | ENSP00000424021.1 |
Frequencies
GnomAD3 genomes AF: 0.622 AC: 94522AN: 151978Hom.: 30655 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
94522
AN:
151978
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.622 AC: 94644AN: 152096Hom.: 30716 Cov.: 32 AF XY: 0.615 AC XY: 45722AN XY: 74350 show subpopulations
GnomAD4 genome
AF:
AC:
94644
AN:
152096
Hom.:
Cov.:
32
AF XY:
AC XY:
45722
AN XY:
74350
show subpopulations
African (AFR)
AF:
AC:
33960
AN:
41530
American (AMR)
AF:
AC:
7979
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
1638
AN:
3468
East Asian (EAS)
AF:
AC:
1867
AN:
5170
South Asian (SAS)
AF:
AC:
2718
AN:
4822
European-Finnish (FIN)
AF:
AC:
5558
AN:
10554
Middle Eastern (MID)
AF:
AC:
144
AN:
292
European-Non Finnish (NFE)
AF:
AC:
38935
AN:
67960
Other (OTH)
AF:
AC:
1230
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1696
3391
5087
6782
8478
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
768
1536
2304
3072
3840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1797
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.